-
Subject Areas on Research
-
3-Hydroxykynurenine and clinical symptoms in first-episode neuroleptic-naive patients with schizophrenia.
-
A Multicenter, Rater-Blinded, Randomized Controlled Study of Auditory Processing-Focused Cognitive Remediation Combined With Open-Label Lurasidone in Patients With Schizophrenia and Schizoaffective Disorder.
-
A Recovery-Oriented Intervention for People With Psychosis: A Pilot Randomized Controlled Trial.
-
A comparison of psychotic and nonpsychotic substance users in the psychiatric emergency room.
-
A comparison of stereology and segmentation techniques for volumetric measurements of lateral ventricles in magnetic resonance imaging.
-
A follow-up study of post partum illness, 1946-1978.
-
A longitudinal study of neurocognitive function in individuals at-risk for psychosis.
-
A pilot study of a weight management program with food provision in schizophrenia.
-
A pilot study of assertive community treatment for patients with chronic psychotic disorders.
-
A population-based cohort study of premorbid intellectual, language, and behavioral functioning in patients with schizophrenia, schizoaffective disorder, and nonpsychotic bipolar disorder.
-
A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale.
-
A randomized controlled trial of allopurinol vs. placebo added on to antipsychotics in patients with schizophrenia or schizoaffective disorder.
-
A randomized controlled trial of outpatient commitment in North Carolina.
-
A randomized trial examining the effectiveness of switching from olanzapine, quetiapine, or risperidone to aripiprazole to reduce metabolic risk: comparison of antipsychotics for metabolic problems (CAMP).
-
A research network to evaluate assertive community treatment: introduction.
-
A scoring system derived from electronic health records to identify patients at high risk for noninvasive ventilation failure.
-
A single assessment with the Brief Adherence Rating Scale (BARS) discriminates responders to long-acting injectable antipsychotic treatment in patients with schizophrenia.
-
A trial of compliance therapy in outpatients with schizophrenia or schizoaffective disorder.
-
ACR Appropriateness Criteria® Acute Mental Status Change, Delirium, and New Onset Psychosis.
-
Abnormalities of the corpus callosum in nonpsychotic children with chromosome 22q11 deletion syndrome.
-
Actigraphic-measured sleep disturbance predicts increased positive symptoms in adolescents at ultra high-risk for psychosis: A longitudinal study.
-
Acute psychotic disorder after gastric bypass surgery: differential diagnosis and treatment.
-
Adolescents at clinical-high risk for psychosis: Circadian rhythm disturbances predict worsened prognosis at 1-year follow-up.
-
Aggression and psychopathology in treatment-resistant inpatients with schizophrenia and schizoaffective disorder.
-
Alteration of accessibility with scopolamine.
-
Altered functional connectivity in psychotic disorder not otherwise specified.
-
Altered striatal functional connectivity in subjects with an at-risk mental state for psychosis.
-
Alzheimer disease with psychosis: excess cognitive impairment is restricted to the misidentification subtype.
-
An empirical evaluation of the Arizona sexual experience scale and a simple one-item screening test for assessing antipsychotic-related sexual dysfunction in outpatients with schizophrenia and schizoaffective disorder.
-
An evidence synthesis of care models to improve general medical outcomes for individuals with serious mental illness: a systematic review.
-
An obsessional variant of capgras symptom: a case report.
-
Anticipating DSM-V: opportunities and challenges for cognition and psychosis.
-
Antidepressant drug therapy in psychotic depression.
-
Antipsychotic-induced weight gain and therapeutic response: a differential association.
-
Antipsychotics and the risk of sudden cardiac death.
-
Assessing the New York City involuntary outpatient commitment pilot program.
-
Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome.
-
Association between genetic and socioenvironmental risk for schizophrenia during upbringing in a UK longitudinal cohort.
-
Association of Air Pollution Exposure in Childhood and Adolescence With Psychopathology at the Transition to Adulthood.
-
Association of neuropsychiatric symptoms and sub-syndromes with cognitive impairment in community-dwelling Asian elderly.
-
Associations between residence at birth and mental health disorders: a spatial analysis of retrospective cohort data.
-
Attention deficit hyperactivity disorder symptoms as antecedents of later psychotic outcomes in 22q11.2 deletion syndrome.
-
Autism, Psychosis, or Both? Unraveling Complex Patient Presentations.
-
BDNF Val66Met and spontaneous dyskinesias in non-clinical psychosis.
-
Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit.
-
Bifactor and item response theory analyses of interviewer report scales of cognitive impairment in schizophrenia.
-
Brain volumes in psychotic youth with schizophrenia and mood disorders.
-
COVID-19-associated brief psychotic disorder.
-
COVID-19-associated psychosis: A systematic review of case reports.
-
Can IQ moderate the response to cognitive remediation in people with schizophrenia?
-
Can involuntary outpatient commitment reduce hospital recidivism?: Findings from a randomized trial with severely mentally ill individuals.
-
Candidate neuroanatomic substrates of psychosis in old-aged depression.
-
Case 14-2016: A Woman with a Thyroid Nodule and Psychosis.
-
Cerebellar networks in individuals at ultra high-risk of psychosis: impact on postural sway and symptom severity.
-
Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
-
Characteristics of third-party money management for persons with psychiatric disabilities.
-
Characterization of Severe and Extreme Behavioral Problems in Patients With Alternating Hemiplegia of Childhood.
-
Childhood origins of violent behaviour in adults with schizophreniform disorder.
-
Childhood trauma and children's emerging psychotic symptoms: A genetically sensitive longitudinal cohort study.
-
Children's self-reported psychotic symptoms and adult schizophreniform disorder: a 15-year longitudinal study.
-
Cholinesterase inhibitors as adjunctive therapy in patients with schizophrenia and schizoaffective disorder: a review and meta-analysis of the literature.
-
Clinical characteristics of Kraepelinian schizophrenia: replication and extension of previous findings.
-
Clinical outcome in a randomized 1-year trial of clozapine versus treatment as usual for patients with treatment-resistant illness and a history of mania.
-
Clinical, demographic and social characteristics of psychotic depression.
-
Clozapine treatment for suicidality in schizophrenia: International Suicide Prevention Trial (InterSePT).
-
Clozapine-induced electroencephalogram changes as a function of clozapine serum levels.
-
Cognitive burden of anticholinergic medications in psychotic disorders.
-
Cognitive decline preceding the onset of psychosis in patients with 22q11.2 deletion syndrome.
-
Cognitive effects of antipsychotic drugs in first-episode schizophrenia and schizophreniform disorder: a randomized, open-label clinical trial (EUFEST).
-
Collaborative Care in the Identification and Management of Psychosis in Adolescents and Young Adults.
-
Community adjustment among the elderly: psychopharmacological patterns and diagnoses.
-
Comorbid posttraumatic stress disorder is associated with suicidality in male veterans with schizophrenia or schizoaffective disorder.
-
Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol.
-
Comparative efficacy and safety of atypical and conventional antipsychotic drugs in first-episode psychosis: a randomized, double-blind trial of olanzapine versus haloperidol.
-
Comparative mortality risks of antipsychotic medications in community-dwelling older adults.
-
Comparing experiential acceptance and cognitive reappraisal as predictors of functional outcome in individuals with serious mental illness.
-
Comparison of seizure duration, ictal EEG, and cognitive effects of ketamine and methohexital anesthesia with ECT.
-
Comparison of self-report and clinician ratings on two inventories of depressive symptomatology.
-
Competence to complete psychiatric advance directives: effects of facilitated decision making.
-
Completing the puzzle: The search for pieces in the understanding of psychosis risk in 22q11.2 deletion syndrome.
-
Corticolimbic brain anomalies are associated with cognitive subtypes in psychosis: A longitudinal study.
-
Cost effectiveness of maintenance ECT.
-
Cost-Effectiveness of Long-Acting Injectable Paliperidone Palmitate Versus Haloperidol Decanoate in Maintenance Treatment of Schizophrenia.
-
Criminal victimization of persons with severe mental illness.
-
Cumulative Effects of Neighborhood Social Adversity and Personal Crime Victimization on Adolescent Psychotic Experiences.
-
DSM melancholic features are unreliable predictors of ECT response: a CORE publication.
-
Deep-vein thrombosis with antipsychotic drugs.
-
Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis.
-
Deficits in generalized cognitive ability, visual sensorimotor function, and inhibitory control represent discrete domains of neurobehavioral deficit in psychotic disorders.
-
Development of the Brief Bipolar Disorder Symptom Scale for patients with bipolar disorder.
-
Deviation from expected cognitive ability across psychotic disorders.
-
Diagnostic utility of the dexamethasone suppression test.
-
Disrupted salience network functional connectivity and white-matter microstructure in persons at risk for psychosis: findings from the LYRIKS study.
-
Dissemination of evidence-based mental health interventions: importance to the trauma field.
-
Does involuntary outpatient commitment lead to more intensive treatment?
-
Drug interaction between carbapenems and extended-release divalproex sodium in a patient with schizoaffective disorder.
-
Duration of untreated psychosis and the pathway to care in KwaZulu-Natal, South Africa.
-
ECT remission rates in psychotic versus nonpsychotic depressed patients: a report from CORE.
-
Effect of ECT treatment number on the ictal EEG.
-
Effectiveness of lurasidone in patients with schizophrenia or schizoaffective disorder switched from other antipsychotics: a randomized, 6-week, open-label study.
-
Effectiveness of switching from antipsychotic polypharmacy to monotherapy.
-
Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
-
Effects of olanzapine, quetiapine, and risperidone on neurocognitive function in early psychosis: a randomized, double-blind 52-week comparison.
-
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
-
Efficacy and tolerability of olanzapine, quetiapine, and risperidone in the treatment of early psychosis: a randomized, double-blind 52-week comparison.
-
Electroconvulsive therapy in the presence of brain tumor. Case reports and an evaluation of risk.
-
Electronic monitoring of antipsychotic medication adherence in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of its reliability and predictive validity.
-
Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories.
-
Emergency department visits among patients transported by law enforcement officers.
-
Emotion recognition and social/role dysfunction in non-clinical psychosis.
-
Endorsement of personal benefit of outpatient commitment among persons with severe mental illness.
-
Etiological and clinical features of childhood psychotic symptoms: results from a birth cohort.
-
Etiological features of borderline personality related characteristics in a birth cohort of 12-year-old children.
-
Evaluation of Proactive Community Case Detection to Increase Help Seeking for Mental Health Care: A Pragmatic Randomized Controlled Trial.
-
Eveningness chronotype preference among individuals at clinical high risk for psychosis.
-
Evidence for early-childhood, pan-developmental impairment specific to schizophreniform disorder: results from a longitudinal birth cohort.
-
Exploratory analysis of social cognition and neurocognition in individuals at clinical high risk for psychosis.
-
Externalizing the threat from within: A new direction for researching associations between suicide and psychotic experiences.
-
Factor structure of the positive and negative syndrome scale (PANSS) in people at ultra high risk (UHR) for psychosis.
-
Feasibility and pilot efficacy results from the multisite Cognitive Remediation in the Schizophrenia Trials Network (CRSTN) randomized controlled trial.
-
First- and second-generation antipsychotics.
-
Genetic contributors to risk of schizophrenia in the presence of a 22q11.2 deletion.
-
Genome-wide association study accounting for anticholinergic burden to examine cognitive dysfunction in psychotic disorders.
-
Guidance for switching from off-label antipsychotics to pimavanserin for Parkinson's disease psychosis: an expert consensus.
-
Heterogeneity of tardive dyskinesia. A multivariate analysis.
-
Hierarchical temporal processing deficit model of reality distortion and psychoses.
-
Hospitalized schizophrenic patient views about seclusion.
-
Hypothalamic-pituitary-adrenal axis dysfunction in non-clinical psychosis.
-
Hysterical psychosis and epilepsy: differential diagnosis.
-
Identification of patients with recent-onset psychosis in KwaZulu Natal, South Africa: a pilot study with traditional health practitioners and diagnostic instruments.
-
Identifying clinical competencies that support rehabilitation and empowerment in individuals with severe mental illness.
-
Impact of Service User Video Presentations on Explicit and Implicit Stigma toward Mental Illness among Medical Students in Nepal: A Randomized Controlled Trial.
-
Impact of polygenic risk for coronary artery disease and cardiovascular medication burden on cognitive impairment in psychotic disorders.
-
Impact of psychiatric comorbidity in individuals at Ultra High Risk of psychosis - Findings from the Longitudinal Youth at Risk Study (LYRIKS).
-
Impaired Context Processing is Attributable to Global Neuropsychological Impairment in Schizophrenia and Psychotic Bipolar Disorder.
-
Implementation of the Texas Medication Algorithm Project patient and family education program.
-
Implementing the protocol of a pilot randomized controlled trial for the recovery-oriented intervention to people with psychoses in two Latin American cities.
-
In the eye of the beholder: Perceptions of neighborhood adversity and psychotic experiences in adolescence.
-
Increased morbid risk for schizophrenia-related disorders in relatives of schizotypal personality disordered patients.
-
Increased pituitary volume in ...psychosis study.
-
Initial level of care and clinical status in a managed mental health program.
-
Insight in first-episode psychosis.
-
Interpersonal trauma, war zone exposure, and posttraumatic stress disorder among veterans with schizophrenia.
-
Lack of Evidence for Regional Brain Volume or Cortical Thickness Abnormalities in Youths at Clinical High Risk for Psychosis: Findings From the Longitudinal Youth at Risk Study.
-
Large-Scale Network Topology Reveals Heterogeneity in Individuals With at Risk Mental State for Psychosis: Findings From the Longitudinal Youth-at-Risk Study.
-
Latent Profile Analysis and Conversion to Psychosis: Characterizing Subgroups to Enhance Risk Prediction.
-
Lifetime comorbidity, lifetime history of psychosis and suicide attempts, and current symptoms of patients with deteriorated affective disorder.
-
Liminal Space of First-Episode Psychosis: Health Management and Its Effect on Social Participation.
-
Links between research findings and the future of assertive community treatment: a commentary.
-
Long-term neurocognitive effects of olanzapine or low-dose haloperidol in first-episode psychosis.
-
Longitudinal Associations of Mental Disorders With Dementia: 30-Year Analysis of 1.7 Million New Zealand Citizens.
-
Longitudinal Cognitive Changes in Young Individuals at Ultrahigh Risk for Psychosis.
-
Management of Gardner-Diamond syndrome with therapeutic plasma exchange.
-
Managing common behavioral problems in dementia. How to improve quality of life for patients and families.
-
Medication nonadherence and substance abuse in psychotic disorders: impact of depressive symptoms and social stability.
-
Medication optimization during clozapine treatment.
-
Medication preferences and adherence among individuals with severe mental illness and psychiatric advance directives.
-
Mental Health and Functional Outcomes in Young Adulthood of Children With Psychotic Symptoms: A Longitudinal Cohort Study.
-
Mental disorders and violence in a total birth cohort: results from the Dunedin Study.
-
Mental health problems in juvenile justice populations.
-
Metabolic dysfunctions in the kynurenine pathway, noradrenergic and purine metabolism in schizophrenia and bipolar disorders.
-
Metabolic effects associated with atypical antipsychotic treatment in the developmentally disabled.
-
Metformin for weight loss and metabolic control in overweight outpatients with schizophrenia and schizoaffective disorder.
-
Methodological issues in assertive community treatment studies.
-
Methylomic Investigation of Problematic Adolescent Cannabis Use and Its Negative Mental Health Consequences.
-
Methylomic analysis of monozygotic twins discordant for childhood psychotic symptoms.
-
Mobile device use among inpatients on a psychiatric unit: A preliminary study.
-
Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene X environment interaction.
-
Naltrexone treatment of self-injurious behavior.
-
Neuropsychiatric Issues in Parkinson's Disease.
-
Neuropsychiatric disturbance in Alzheimer's disease clusters into three groups: the Cache County study.
-
Neuropsychiatric manifestations of porphyria.
-
Neuropsychological impairments in schizophrenia and psychotic bipolar disorder: findings from the Bipolar-Schizophrenia Network on Intermediate Phenotypes (B-SNIP) study.
-
Neuropsychological performance at the age of 13 years and adult schizophreniform disorder: prospective birth cohort study.
-
Neuropsychological status of subjects at high risk for a first episode of psychosis.
-
Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis.
-
No evidence for the presence of genetic variants predisposing to psychotic disorders on the non-deleted 22q11.2 allele of VCFS patients.
-
Nondisease-specific problems and all-cause mortality in the REasons for Geographic and Racial Differences in Stroke study.
-
Olanzapine and haloperidol in first episode psychosis: two-year data.
-
Olanzapine in refractory schizophrenia after failure of typical or atypical antipsychotic treatment: an open-label switch study.
-
Olanzapine, new-onset diabetes mellitus, and risk for insulin overdose.
-
On sample size calculation based on odds ratio in clinical trials.
-
Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose.
-
Orbitofrontal cortex volume and intrinsic religiosity in non-clinical psychosis.
-
Performance and interview-based assessments of cognitive change in a randomized, double-blind comparison of lurasidone vs. ziprasidone.
-
Pharmacologic treatment of psychiatric disease in pregnancy and lactation: fetal and neonatal effects.
-
Pharmacological management of first-episode schizophrenia and related nonaffective psychoses.
-
Physical activity level and medial temporal health in youth at ultra high-risk for psychosis.
-
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.
-
Polygenic risk for schizophrenia and measured domains of cognition in individuals with psychosis and controls.
-
Polypharmacy in pregnant women with major psychiatric illness: a pilot study.
-
Postpartum psychiatric syndromes.
-
Practical issues in the use of electroconvulsive therapy (ECT).
-
Predicting suicidal risk in schizophrenic and schizoaffective patients in a prospective two-year trial.
-
Predictors of High-Intensity Psychiatric Service Utilization by Veterans Health Administration Patients With Early Psychosis.
-
Predictors of antipsychotic treatment response in patients with first-episode schizophrenia, schizoaffective and schizophreniform disorders.
-
Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
-
Preserved working memory and altered brain activation in persons at risk for psychosis.
-
Principal components of heritability from neurocognitive domains differ between families with schizophrenia and control subjects.
-
Promoting mental health recovery and improving clinical assessment using video technology.
-
Protective factors for psychotic experiences amongst adolescents exposed to multiple forms of victimization.
-
Psychiatric and psychosocial correlates of sexual risk behavior among adults with severe mental illness.
-
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome.
-
Psychiatric disorders in inhalant users: results from The National Epidemiologic Survey on Alcohol and Related Conditions.
-
Psychosis in Parkinson's disease: diagnosis and treatment.
-
Psychosis in bipolar disorder: phenomenology and impact on morbidity and course of illness.
-
Psychotic disorder in a patient with central and extrapontine myelinolysis.
-
Psychotic disorders cause the greatest mortality disparity among mental disorders, though more deaths are attributable overall to mood and anxiety disorders.
-
Psychotic experiences and risk of death in the general population: 24-27 year follow-up of the Epidemiologic Catchment Area study.
-
Psychotic symptoms in Alzheimer disease: evidence for subtypes.
-
Quality of life during treatment with haloperidol or olanzapine in the year following a first psychotic episode.
-
Real-world effectiveness of long-acting injectable antipsychotics to reduce 90-day and annual readmission in psychotic disorders: insights from a state psychiatric hospital.
-
Regional cerebral blood flow alterations in unipolar depression.
-
Regressing to Prior Response Preference After Set Switching Implicates Striatal Dysfunction Across Psychotic Disorders: Findings From the B-SNIP Study.
-
Reliability and validity of the SF-12 health survey among people with severe mental illness.
-
Religious coping and quality of life among individuals living with schizophrenia.
-
Research on religion, spirituality, and mental health: a review.
-
Retinal microvessels reflect familial vulnerability to psychotic symptoms: A comparison of twins discordant for psychotic symptoms and controls.
-
Richard Dadd and the Fairy Feller's Master-Stroke.
-
Seclusion on an adolescent unit.
-
Self-reported sleep disturbances associated with procedural learning impairment in adolescents at ultra-high risk for psychosis.
-
Sexual dysfunction associated with second-generation antipsychotics in outpatients with schizophrenia or schizoaffective disorder: an empirical evaluation of olanzapine, risperidone, and quetiapine.
-
Sexual functioning associated with quetiapine switch vs. risperidone continuation in outpatients with schizophrenia or schizoaffective disorder: a randomized double-blind pilot trial.
-
Sleep disturbance in euthymic bipolar patients.
-
Sleep dysfunction and thalamic abnormalities in adolescents at ultra high-risk for psychosis.
-
Smoking and psychosis in patients with bipolar I disorder.
-
Social cognition as a mediator between neurocognition and functional outcome in individuals at clinical high risk for psychosis.
-
Social functioning in urban, predominantly African American, socially disadvantaged patients with first-episode nonaffective psychosis.
-
Social skills, negative symptoms and real-world functioning in individuals at ultra-high risk of psychosis.
-
Spanish validation of the Brief Assessment in Cognition in Schizophrenia (BACS) in patients with schizophrenia and healthy controls.
-
Specificity of childhood psychotic symptoms for predicting schizophrenia by 38 years of age: a birth cohort study.
-
Spirituality and religion in outpatients with schizophrenia: a multi-site comparative study of Switzerland, Canada, and the United States.
-
Stigma and treatment delay in first-episode psychosis: a grounded theory study.
-
Storm clouds over the public mental health safety net.
-
Striatal abnormalities and spontaneous dyskinesias in non-clinical psychosis.
-
Structured lifestyle education to support weight loss for people with schizophrenia, schizoaffective disorder and first episode psychosis: the STEPWISE RCT.
-
Substance use among patients with a psychotic disorder in a psychiatric emergency room.
-
Subsyndromal and syndromal depressive symptoms among older adults with schizophrenia spectrum disorder: Prevalence and associated factors in a multicenter study.
-
Subthreshold Psychosis in 22q11.2 Deletion Syndrome: Multisite Naturalistic Study.
-
Taking the wrong drugs: the role of substance abuse and medication noncompliance in violence among severely mentally ill individuals.
-
Test-retest reliability of the dot test of visuospatial working memory in patients with schizophrenia and controls.
-
Texas Medication Algorithm Project, phase 3 (TMAP-3): clinical results for patients with a history of mania.
-
The Brief Adherence Rating Scale (BARS) validated against electronic monitoring in assessing the antipsychotic medication adherence of outpatients with schizophrenia and schizoaffective disorder.
-
The Cognitive Assessment Interview (CAI): reliability and validity of a brief interview-based measure of cognition.
-
The Function Biomedical Informatics Research Network Data Repository.
-
The History of Coordinated Specialty Care for Early Intervention in Psychosis in the United States: A Review of Effectiveness, Implementation, and Fidelity.
-
The Longitudinal Youth at Risk Study (LYRIKS)--an Asian UHR perspective.
-
The MATRICS Consensus Cognitive Battery, part 1: test selection, reliability, and validity.
-
The MCCB impairment profile for schizophrenia outpatients: results from the MATRICS psychometric and standardization study.
-
The Role of Cognition and Social Functioning as Predictors in the Transition to Psychosis for Youth With Attenuated Psychotic Symptoms.
-
The SNAP-25 gene may be associated with clinical response and weight gain in antipsychotic treatment of schizophrenia.
-
The Singapore flagship programme in translational and clinical research in psychosis.
-
The chronically mentally ill in primary care.
-
The course of cognitive functioning over six months in individuals at clinical high risk for psychosis.
-
The experience of care partners of patients with Parkinson's disease psychosis.
-
The impact of eszopiclone on sleep and cognition in patients with schizophrenia and insomnia: a double-blind, randomized, placebo-controlled trial.
-
The international suicide prevention trial (interSePT): rationale and design of a trial comparing the relative ability of clozapine and olanzapine to reduce suicidal behavior in schizophrenia and schizoaffective patients.
-
The ketogenic diet and remission of psychotic symptoms in schizophrenia: Two case studies.
-
The period of untreated psychosis before treatment initiation: a qualitative study of family members' perspectives.
-
The relationship between stress responding in family context and stress sensitivity with sleep dysfunction in individuals at clinical high-risk for psychosis.
-
The response of an assertive community treatment program following a natural disaster.
-
The severely mentally ill in general hospital psychiatric units.
-
The social-environmental context of violent behavior in persons treated for severe mental illness.
-
Three children with a syndrome of obesity and overgrowth, atypical psychosis, and seizures: a problem in neuropsychopharmacology.
-
Training the Next Generation of Clinical Psychological Scientists: A Data-Driven Call to Action.
-
Treatment of thyrotoxicosis-induced psychosis.
-
Unitary construct of generalized cognitive ability underlying BACS performance across psychotic disorders and in their first-degree relatives.
-
Use of lamotrigine in a patient with a clozapine-related seizure.
-
Utility of the Faschingbauer abbreviated MMPI as a function of patient group and sex.
-
Validation of the German version of the brief assessment of cognition in Schizophrenia (BACS) - preliminary results.
-
Validity of electronically monitored medication adherence and conventional adherence measures in schizophrenia.
-
Validity of the NIMH Diagnostic Interview Schedule for Children: a comparison between psychiatric and pediatric referrals.
-
Violence and severe mental disorder in clinical and community populations: the effects of psychotic symptoms, comorbidity, and lack of treatment.
-
Violent behavior preceding hospitalization among persons with severe mental illness.
-
Virtual reality assessment of functional capacity in the early course of schizophrenia: Associations with cognitive performance and daily functioning.
-
Whole blood serotonin relates to violence in an epidemiological study.
-
Why Are Children in Urban Neighborhoods at Increased Risk for Psychotic Symptoms? Findings From a UK Longitudinal Cohort Study.
-
Working memory impairment in probands with schizoaffective disorder and first degree relatives of schizophrenia probands extend beyond deficits predicted by generalized neuropsychological impairment.
-
Keywords of People